Billing & Fee Schedule

Investigational Drug Service Fee Schedule

Pharmacy Fees (studies utilizing Pharmacy)

Annual Pharmacy Fees
Commercial Sponsor $2000/year
Non-Profit Sponsor $1000/year

These fees are not part of the investigator compensation and include:

  • Assistance in execution of the scientific, clinical and administrative functions of drug research.
  • Assurance that drug studies are conducted in a safe, effective and efficient manner.
  • Assure compliance with all federal, state and IRB regulations concerning medication used on investigational studies.
  • Patient counseling (if needed) about the study drug's mechanism of action, side effects, food interactions and dosing regimen.
  • Dispensing and labeling of medications used on investigational studies.
  • Completion of study medication accountability records.
  • Ordering and maintenance of study medications and supplies.
  • Storage of study medications and supplies.
  • Assist in the investigation and reporting of adverse drug reactions.
  • On-site medication destruction (if needed) of investigational materials.
  • Storage of all clinical study pharmacy records after study closure.
  • Review, supervision and monitoring of medications related to the study.

Preparation Fees
Non-sterile preparation $25/prescription fill
Sterile preparation (non-hazardous) $75/prescription fill
Sterile preparation (hazardous [chemo]) $125/prescription fill

Compliance & Oversight* Fee (studies not utilizing Pharmacy) = $250/year.

Billing

New Study

At the start of the study, the initial Annual Pharmacy Fee will be budgeted along with other initial start-up fees such as the IRB fee. The Pharmacy research team will meet with the study coordinator to determine which services will be needed, along with any other medication and supplies costs necessary. These charges will be included in the budget for the study.

Ongoing Study

Annual Pharmacy Fees will be billed annually. Preparation fees will be billed on an on-going basis throughout the course of the study.

*See the Regulatory Requirements section for further information.